Home › Funds › Bridgewater Associates › HCA

Bridgewater Associates position in HCA

HCA HEALTHCARE INC · Health Care

Bridgewater Associates reported holding 202,141 shares of HCA (HCA HEALTHCARE INC) in its Q3 2026 13F filing — a position valued at US$86.3M, representing 0.38% of its reported portfolio and ranking #49 among its reported holdings. Bridgewater Associates has disclosed HCA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)202.14K sh
Reported value held$86.26M
Portfolio Weight0.38%
First reportedQ3 2021
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Bridgewater Associates's HCA position evolved

Bridgewater Associates first disclosed a stake in HCA in Q3 2021 at 341,375 shares (US$82.9M). The position peaked in Q2 2025 at 406,706 shares, worth US$155.8M. Across 21 filings, Bridgewater Associates increased the stake 6 time(s), trimmed it 14 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 202,141 shares valued at US$86.3M — a reduction of -1,063 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2022 (shares rose 9% over the following quarter), a 88% increase in Q4 2024 (shares rose 15% over the following quarter), a 47% trim in Q1 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 341.38K $82.86M New
Q4 2021 312.87K $80.38M Reduce
Q1 2022 389.35K $97.58M Add
Q2 2022 495.52K $83.28M Add
Q3 2022 372.04K $68.38M Reduce
Q4 2022 345.45K $82.90M Reduce
Q1 2023 340.74K $89.85M Reduce
Q2 2023 302.74K $91.88M Reduce
Q3 2023 375.71K $92.42M Add
Q4 2023 426.28K $115.38M Add
Q1 2024 346.31K $115.51M Reduce
Q2 2024 295.90K $95.07M Reduce
Q3 2024 250.04K $101.62M Reduce
Q4 2024 470.55K $141.24M Add
Q1 2025 428.73K $148.15M Reduce
Q2 2025 406.71K $155.81M Reduce
Q3 2025 340.56K $145.15M Reduce
Q4 2025 329.31K $153.74M Reduce
Q1 2026 173.80K $82.25M Reduce
Q2 2026 203.20K $79.23M Add
Q3 2026 202.14K $86.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HCA and 13F data

HCA (HCA HEALTHCARE INC) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.75B), First Eagle Investment Management (US$1.39B), Arrowstreet Capital (US$851.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HCA

All HCA fund holders →

FAQ

How long has Bridgewater Associates held HCA?

Bridgewater Associates has disclosed HCA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Bridgewater Associates's current position in HCA?

As of Q3 2026, Bridgewater Associates holds 202.14K shares of HCA (HCA HEALTHCARE INC), valued at $86.26M, representing 0.38% of its reported portfolio and ranking #49.

Has Bridgewater Associates been buying or selling HCA?

In the latest 13F filing (Q3 2026), Bridgewater Associates reduced its position in HCA. The position peaked in Q2 2025 at 406.71K shares.

Which other funds hold HCA?

Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.